This study highlights the potential prognostic value in assessing the levels of ROR1 and/or ROR2 in untreated high-risk early-stage breast cancer and justifies further studies to evaluate the biology and possible value of targeting ROR1 and ROR2 with investigational treatments. Here, ROR2 is linked to breast cancer.